Amphastar P (AMPH)
Number of days of payables
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Payables turnover | 11.53 | 8.61 | 14.05 | 11.45 | 12.20 | 12.57 | 8.06 | 10.25 | 10.72 | 10.73 | 7.87 | 9.43 | 8.48 | 8.52 | 9.00 | 11.48 | 7.60 | 8.87 | 6.26 | 5.69 | |
Number of days of payables | days | 31.66 | 42.41 | 25.97 | 31.86 | 29.92 | 29.04 | 45.31 | 35.59 | 34.06 | 34.01 | 46.39 | 38.72 | 43.05 | 42.84 | 40.55 | 31.81 | 48.03 | 41.17 | 58.34 | 64.10 |
December 31, 2023 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 11.53
= 31.66
Amphastar Pharmaceuticals Inc's number of days of payables has been fluctuating over the past eight quarters, ranging from as low as 25.97 days to as high as 45.31 days. In Q3 2022, the number of days of payables was at its highest at 45.31 days before decreasing in the subsequent quarters. The company seems to have effectively managed its payables in Q2 and Q4 2023, with the number of days being below 35 days. This indicates that the company takes, on average, around 31 to 42 days to pay its suppliers and vendors. Monitoring this ratio can provide insights into the company's working capital management and payment practices.
Peer comparison
Dec 31, 2023